Lv41
490 积分 2021-08-30 加入
Leading AI-Driven Drug Discovery Platforms: 2025 Landscape and Global Outlook
4天前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
10天前
已完结
An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors
13天前
已完结
Validation of a clinically relevant humanized mouse model for the safety assessment of 4-1BB agonists utomilumab and urelumab
14天前
已关闭
A BACH1 inhibitor ameliorates myocardial infarction and limb ischemia in mice
1个月前
已完结
Genetic and transcriptional evolution alters cancer cell line drug response
1个月前
已完结
Theranostic role of 89Zr- and 177Lu-labeled aflibercept in breast cancer
2个月前
已完结
Discovery of the First Potent PI3K/mTOR Dual-Targeting PROTAC Degrader for Efficient Modulation of the PI3K/AKT/mTOR Pathway
2个月前
已完结
1012P First-in-human study of ABSK-011, a novel, highly selective fibroblast growth factor receptor (FGFR) 4 inhibitor for treating advanced hepatocellular carcinoma (HCC) with FGF19 overexpression
2个月前
已关闭
1012P First-in-human study of ABSK-011, a novel, highly selective fibroblast growth factor receptor (FGFR) 4 inhibitor for treating advanced hepatocellular carcinoma (HCC) with FGF19 overexpression
2个月前
已关闭
皖公网安备34019202002308
